Abciximab reduced death, MI, and urgent target vessel revascularization in non–ST-segment elevation acute coronary syndromes

摘要

Despite updated ACC/AHA guidelines and many clinical trials, controversynexists over the optimal therapy for ACS. After prescribing aspirinnand heparin, cardiologists wrestle with clinical issues of whether allnpatients should receive clopidogrel before coronary angiography,nwhether GP IIb/IIIa antagonists should be started early or only duringnPCI, and whether high-dose clopidogrel before PCI might obviate thenneed for GP IIb/IIIa antagonists.